메뉴 건너뛰기




Volumn 89, Issue 4, 2012, Pages 294-301

Outcome of allogeneic stem cell transplantation in myelodysplastic syndrome patients: Prognostic implication of monosomal karyotype

Author keywords

Allogeneic stem cell transplantation; Monosomal karyotype; Myelodysplastic syndrome

Indexed keywords

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; EVENT FREE SURVIVAL; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84866359435     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01830.x     Document Type: Article
Times cited : (11)

References (26)
  • 1
    • 0030897009 scopus 로고    scopus 로고
    • International scoring system for evaluating prognosis in myelodysplastic syndromes
    • Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88.
    • (1997) Blood , vol.89 , pp. 2079-2088
    • Greenberg, P.1    Cox, C.2    LeBeau, M.M.3
  • 2
    • 54349092877 scopus 로고    scopus 로고
    • Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype
    • Breems DA, Van Putten WL, De Greef GE, et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008;26:4791-7.
    • (2008) J Clin Oncol , vol.26 , pp. 4791-4797
    • Breems, D.A.1    Van Putten, W.L.2    De Greef, G.E.3
  • 3
    • 84155167315 scopus 로고    scopus 로고
    • Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity
    • Ahn HK, Jang JH, Kim K, Kim HJ, Kim SH, Jung CW, Kim DH. Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity. Am J Hematol 2012;87:37-41.
    • (2012) Am J Hematol , vol.87 , pp. 37-41
    • Ahn, H.K.1    Jang, J.H.2    Kim, K.3    Kim, H.J.4    Kim, S.H.5    Jung, C.W.6    Kim, D.H.7
  • 4
    • 80051609304 scopus 로고    scopus 로고
    • Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation
    • Fang M, Storer B, Estey E, Othus M, Zhang L, Sandmaier BM, Appelbaum FR. Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation. Blood 2011;118:1490-4.
    • (2011) Blood , vol.118 , pp. 1490-1494
    • Fang, M.1    Storer, B.2    Estey, E.3    Othus, M.4    Zhang, L.5    Sandmaier, B.M.6    Appelbaum, F.R.7
  • 5
    • 79551681707 scopus 로고    scopus 로고
    • Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia
    • Oran B, Dolan M, Cao Q, Brunstein C, Warlick E, Weisdorf D. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia. Biol Blood Marrow Transplant 2011;17:356-64.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 356-364
    • Oran, B.1    Dolan, M.2    Cao, Q.3    Brunstein, C.4    Warlick, E.5    Weisdorf, D.6
  • 6
    • 79960661181 scopus 로고    scopus 로고
    • Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities
    • Perrot A, Luquet I, Pigneux A, et al. Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities. Blood 2011;118:679-85.
    • (2011) Blood , vol.118 , pp. 679-685
    • Perrot, A.1    Luquet, I.2    Pigneux, A.3
  • 7
    • 79959959049 scopus 로고    scopus 로고
    • Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial
    • Stelljes M, Beelen DW, Braess J, et al. Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial. Haematologica 2011;96:972-9.
    • (2011) Haematologica , vol.96 , pp. 972-979
    • Stelljes, M.1    Beelen, D.W.2    Braess, J.3
  • 8
    • 84855857727 scopus 로고    scopus 로고
    • Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies
    • Kayser S, Zucknick M, Dohner K, et al. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood 2012;119:551-8.
    • (2012) Blood , vol.119 , pp. 551-558
    • Kayser, S.1    Zucknick, M.2    Dohner, K.3
  • 9
    • 84857734093 scopus 로고    scopus 로고
    • TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
    • Rucker FG, Schlenk RF, Bullinger L, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood 2012;119:2114-21.
    • (2012) Blood , vol.119 , pp. 2114-2121
    • Rucker, F.G.1    Schlenk, R.F.2    Bullinger, L.3
  • 10
    • 79953047317 scopus 로고    scopus 로고
    • Autosomal monosomies among 24,262 consecutive cytogenetic studies: prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities
    • Raza S, TaherNazerHussain F, Patnaik M, Knudson R, Van Dyke D, Tefferi A. Autosomal monosomies among 24, 262 consecutive cytogenetic studies: prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities. Am J Hematol 2011;86:353-6.
    • (2011) Am J Hematol , vol.86 , pp. 353-356
    • Raza, S.1    TaherNazerHussain, F.2    Patnaik, M.3    Knudson, R.4    Van Dyke, D.5    Tefferi, A.6
  • 11
    • 79751531643 scopus 로고    scopus 로고
    • Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype
    • Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia 2011;25:266-70.
    • (2011) Leukemia , vol.25 , pp. 266-270
    • Patnaik, M.M.1    Hanson, C.A.2    Hodnefield, J.M.3    Knudson, R.4    Van Dyke, D.L.5    Tefferi, A.6
  • 12
    • 84866355881 scopus 로고    scopus 로고
    • Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS, 2003. Available from:
    • Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS, 2003. Available from: http://ctep.cancer.gov.
  • 13
    • 77957715843 scopus 로고    scopus 로고
    • Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience
    • Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood 2010;116:2224-8.
    • (2010) Blood , vol.116 , pp. 2224-2228
    • Medeiros, B.C.1    Othus, M.2    Fang, M.3    Roulston, D.4    Appelbaum, F.R.5
  • 15
    • 84865160517 scopus 로고    scopus 로고
    • Prognostic impact of monosomal karyotype in patients with myelodysplastic syndrome and abnormal karyotype. A Report From the Spanish Group of MDS (GESMD) [Abstract]
    • ASH Annual Meeting Abstracts) ;:Abstract 1724.
    • Valcárcel D, Adema V, Mallo M, et al. Prognostic impact of monosomal karyotype in patients with myelodysplastic syndrome and abnormal karyotype. A Report From the Spanish Group of MDS (GESMD) [Abstract]. Blood (ASH Annual Meeting Abstracts) 2011;118:Abstract 1724.
    • (2011) Blood , vol.118
    • Valcárcel, D.1    Adema, V.2    Mallo, M.3
  • 16
    • 79960207573 scopus 로고    scopus 로고
    • Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
    • Itzykson R, Thepot S, Eclache V, et al. Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine. Leukemia 2011;25:1207-9.
    • (2011) Leukemia , vol.25 , pp. 1207-1209
    • Itzykson, R.1    Thepot, S.2    Eclache, V.3
  • 17
    • 85018256550 scopus 로고    scopus 로고
    • Monosomal karyotype in myeloid malignancies is prognostically worse even after allogeneic hematopoietc stem cell transplantaion; results from two transplant centers [Abstract]
    • ASH Annual Meeting Abstracts) ;:Abstract 4154.
    • Koichiro M, Shigematsu A, Nakata M, et al. Monosomal karyotype in myeloid malignancies is prognostically worse even after allogeneic hematopoietc stem cell transplantaion; results from two transplant centers [Abstract]. Blood (ASH Annual Meeting Abstracts) 2011;118:Abstract 4154.
    • (2011) Blood , vol.118
    • Koichiro, M.1    Shigematsu, A.2    Nakata, M.3
  • 18
    • 84876106217 scopus 로고    scopus 로고
    • Complex karyotype predicts outcome better than monosomal karyotype in patients with mds/secondary acute leukemia treated with allogeneic hematopoietic stem cell transplantation (HSCT): a Retrospective Survey on Behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]
    • ASH Annual Meeting Abstracts) ;:Abstract 578.
    • Brands-Nijenhuis A, Van Gelder M, De Witte T, Schetelig J, Van Biezen A, Kroeger N. Complex karyotype predicts outcome better than monosomal karyotype in patients with mds/secondary acute leukemia treated with allogeneic hematopoietic stem cell transplantation (HSCT): a Retrospective Survey on Behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]. Blood (ASH Annual Meeting Abstracts) 2010;116:Abstract 578.
    • (2010) Blood , vol.116
    • Brands-Nijenhuis, A.1    Van Gelder, M.2    De Witte, T.3    Schetelig, J.4    Van Biezen, A.5    Kroeger, N.6
  • 19
    • 33745121881 scopus 로고    scopus 로고
    • Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide
    • Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide. Biol Blood Marrow Transplant 2006;12:749-57.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 749-757
    • Hallemeier, C.L.1    Girgis, M.D.2    Blum, W.G.3    Brown, R.A.4    Khoury, H.J.5    Devine, S.M.6    Vij, R.7    Lin, H.S.8    DiPersio, J.F.9    Adkins, D.R.10
  • 20
    • 35648955094 scopus 로고    scopus 로고
    • Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    • Nakamura R, Rodriguez R, Palmer J, et al. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome. Bone Marrow Transplant 2007;40:843-50.
    • (2007) Bone Marrow Transplant , vol.40 , pp. 843-850
    • Nakamura, R.1    Rodriguez, R.2    Palmer, J.3
  • 21
    • 83655184694 scopus 로고    scopus 로고
    • Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome
    • Buchholz S, Dammann E, Stadler M, Krauter J, Beutel G, Trummer A, Eder M, Ganser A. Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome. Eur J Haematol 2012;88:52-60.
    • (2012) Eur J Haematol , vol.88 , pp. 52-60
    • Buchholz, S.1    Dammann, E.2    Stadler, M.3    Krauter, J.4    Beutel, G.5    Trummer, A.6    Eder, M.7    Ganser, A.8
  • 22
    • 80053176430 scopus 로고    scopus 로고
    • Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review
    • Parmar S, de Lima M, Deeg HJ, Champlin R. Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review. Semin Oncol 2011;38:693-704.
    • (2011) Semin Oncol , vol.38 , pp. 693-704
    • Parmar, S.1    de Lima, M.2    Deeg, H.J.3    Champlin, R.4
  • 23
    • 80052576601 scopus 로고    scopus 로고
    • Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life
    • Alatrash G, de Lima M, Hamerschlak N, et al. Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. Biol Blood Marrow Transplant 2011;17:1490-6.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 1490-1496
    • Alatrash, G.1    de Lima, M.2    Hamerschlak, N.3
  • 24
    • 58149196171 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden
    • Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Biol Blood Marrow Transplant 2009;15:30-8.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 30-38
    • Warlick, E.D.1    Cioc, A.2    Defor, T.3    Dolan, M.4    Weisdorf, D.5
  • 25
    • 84866395442 scopus 로고    scopus 로고
    • The novel 5-group cytogenetic risk classification of myelodysplastic syndrome (MDS), monosomal karyotype, and outcome after allogeneic hematopoietic cell transplantation (HCT) [Abstract]
    • Abstract 212.
    • Gerds A, Gooley T, Scott BL, Appelbaum FR, Deeg HJ. The novel 5-group cytogenetic risk classification of myelodysplastic syndrome (MDS), monosomal karyotype, and outcome after allogeneic hematopoietic cell transplantation (HCT) [Abstract]. Biol Blood Marrow Transplant 2012;18:Abstract 212.
    • (2012) Biol Blood Marrow Transplant , vol.18
    • Gerds, A.1    Gooley, T.2    Scott, B.L.3    Appelbaum, F.R.4    Deeg, H.J.5
  • 26
    • 79952079761 scopus 로고    scopus 로고
    • Monosomal karyotype predicts poor outcome for MDS/sAML patients with chromosome 7 abnormalities after allogeneic stem cell transplantation for MDS/sAML: a study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]
    • ASH Annual Meeting Abstracts) ;:Abstract 293.
    • Van Gelder M, Schetelig J, Volin L. Monosomal karyotype predicts poor outcome for MDS/sAML patients with chromosome 7 abnormalities after allogeneic stem cell transplantation for MDS/sAML: a study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]. Blood (ASH Annual Meeting Abstracts) 2009;114:Abstract 293.
    • (2009) Blood , vol.114
    • Van Gelder, M.1    Schetelig, J.2    Volin, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.